MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 162 filers reported holding MERIDIAN BIOSCIENCE INC in Q2 2013. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $10,095,000 | -9.6% | 705,936 | -0.5% | 0.16% | -12.8% |
| Q2 2017 | $11,173,000 | -13.5% | 709,363 | -24.2% | 0.18% | -10.4% |
| Q1 2017 | $12,911,000 | -64.6% | 935,590 | -54.5% | 0.20% | -30.4% |
| Q4 2016 | $36,424,000 | +72.9% | 2,057,906 | +88.4% | 0.29% | -16.7% |
| Q3 2016 | $21,071,000 | -1.2% | 1,092,335 | -0.1% | 0.35% | -4.7% |
| Q2 2016 | $21,331,000 | -5.8% | 1,093,860 | -0.4% | 0.36% | -7.6% |
| Q1 2016 | $22,645,000 | +28.6% | 1,098,713 | +28.1% | 0.39% | +20.5% |
| Q4 2015 | $17,604,000 | -29.5% | 857,873 | -29.1% | 0.33% | -9.9% |
| Q2 2014 | $24,961,000 | -4.1% | 1,209,346 | +1.2% | 0.36% | -6.2% |
| Q1 2014 | $26,031,000 | -19.4% | 1,194,599 | -1.8% | 0.39% | -17.8% |
| Q4 2013 | $32,278,000 | +5.1% | 1,216,653 | -6.4% | 0.47% | +0.2% |
| Q3 2013 | $30,712,000 | +8.0% | 1,299,668 | -1.7% | 0.47% | +2.4% |
| Q2 2013 | $28,430,000 | – | 1,322,322 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 115,571 | $3,034,000 | 2.64% |
| Acuitas Investments, LLC | 160,046 | $4,201,000 | 2.41% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,780,000 | 0.78% |
| GLOBEFLEX CAPITAL L P | 158,664 | $4,165,000 | 0.76% |
| CLARK ESTATES INC/NY | 220,000 | $5,775,000 | 0.74% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 721,176 | $18,931,000 | 0.69% |
| EARNEST PARTNERS LLC | 4,341,834 | $113,973,000 | 0.68% |
| MOODY ALDRICH PARTNERS LLC | 138,844 | $3,645,000 | 0.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 889,269 | $23,343,000 | 0.49% |
| Phocas Financial Corp. | 134,740 | $3,537,000 | 0.47% |